372 related articles for article (PubMed ID: 15357517)
1. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
Jatoi A; Podratz KC; Gill P; Hartmann LC
J Support Oncol; 2004; 2(4):323-34; discussion 334-7. PubMed ID: 15357517
[TBL] [Abstract][Full Text] [Related]
2. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
[TBL] [Abstract][Full Text] [Related]
3. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
4. Management of malignant bowel obstruction.
Ripamonti CI; Easson AM; Gerdes H
Eur J Cancer; 2008 May; 44(8):1105-15. PubMed ID: 18359221
[TBL] [Abstract][Full Text] [Related]
5. Intestinal obstruction.
Baines MJ
Cancer Surv; 1994; 21():147-56. PubMed ID: 8564990
[TBL] [Abstract][Full Text] [Related]
6. The challenge of treating malignant bowel obstruction.
J Support Oncol; 2006 Feb; 4(2):83-4. PubMed ID: 16499129
[No Abstract] [Full Text] [Related]
7. The role of octreotide in malignant bowel obstruction.
Krammer LM
Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
[No Abstract] [Full Text] [Related]
8. How to use octreotide for malignant bowel obstruction.
Ripamonti C; Mercadante S
J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
[No Abstract] [Full Text] [Related]
9. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
[TBL] [Abstract][Full Text] [Related]
10. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
Matulonis UA; Seiden MV; Roche M; Krasner C; Fuller AF; Atkinson T; Kornblith A; Penson R
J Pain Symptom Manage; 2005 Dec; 30(6):563-9. PubMed ID: 16376743
[TBL] [Abstract][Full Text] [Related]
11. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
[TBL] [Abstract][Full Text] [Related]
12. Malignant bowel obstruction: individualized treatment near the end of life.
Soriano A; Davis MP
Cleve Clin J Med; 2011 Mar; 78(3):197-206. PubMed ID: 21364165
[TBL] [Abstract][Full Text] [Related]
13. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
Weber C; Zulian GB
Am J Hosp Palliat Care; 2009; 26(2):84-8. PubMed ID: 19088264
[TBL] [Abstract][Full Text] [Related]
14. Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer.
Caprotti R; Bonardi C; Crippa S; Mussi C; Angelini C; Uggeri F
Minerva Ginecol; 2006 Jun; 58(3):239-44. PubMed ID: 16783296
[TBL] [Abstract][Full Text] [Related]
15. [Intestinal occlusion in cancer].
Medina-Franco H
Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():100-5. PubMed ID: 16881208
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of bowel obstruction in cancer patients.
O'Connor B; Creedon B
Expert Opin Pharmacother; 2011 Oct; 12(14):2205-14. PubMed ID: 21714777
[TBL] [Abstract][Full Text] [Related]
17. Malignant bowel obstruction: a review of current treatment strategies.
Dolan EA
Am J Hosp Palliat Care; 2011 Dec; 28(8):576-82. PubMed ID: 21504999
[TBL] [Abstract][Full Text] [Related]
18. Palliative management of malignant bowel obstruction.
Ripamonti C; Bruera E
Int J Gynecol Cancer; 2002; 12(2):135-43. PubMed ID: 11975672
[TBL] [Abstract][Full Text] [Related]
19. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
Mercadante S; Ferrera P; Villari P; Marrazzo A
J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
[TBL] [Abstract][Full Text] [Related]
20. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
